© 2020 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Global
The Shifting Kaleidoscope of EU Pharma Policy
October 14, 2020
Universal strategy push elicits range of constituency views.
Key Support for Rare Disease Medicine Scheme
September 11, 2020
Orphan drug incentives set to remain in place in Europe.
Health Policy Funding, Hopes at Odds in EU
August 07, 2020
Budget battle threatens efforts to bolster Europe’s pharma strategy.
COVID-19: Expanding Remote Patient Services during Lockdown
July 20, 2020
Stephanie Hill looks at the efforts made by patient solutions providers in the UK to build and support services outside the hospital environment during the pandemic.
Is Drug Production Heading Back to Europe From Abroad?
July 09, 2020
Pandemic sparks call for European manufacturing renaissance.
The Specter of Compulsory Licensing Haunts Vaccine Debate
June 11, 2020
Industry prospects at mercy of public discourse, policy shifts.
A New, Less Friendly Normal Looms for European Drugmakers
May 10, 2020
Pandemic fallout could spell fundamental business and policy shifts.
Iraq: Stabilizing a Growing Market
May 06, 2020
Ali Mosawi writes about the misconceptions of Iraq's often inhospitable landscape, the essential role of international expertise in driving growth, and how the sector has adapted to meet the challenges of the COVID-19 pandemic.
There’s No Easing the Price-vs.-Value Debate
April 08, 2020
With coronavirus a stark backdrop, European initiative pushes for “fair” drug prices to spur investment in pharma innovation.